Company
BTG
LON:BTG
BTG is a growing life sciences company focused on the development and commercialisation of pharmaceuticals targeting neurological and other disorders.
46 stories · page 1 of 3
Investments and investor services
FTSE 100 closes higher Monday, just, as traders sit on hands
Footsie closed around 11 points higher at 7,357 at the start of the week, while mid-cap cousin FTSE 250 gained over 39 points
Archive
Federal Reserve rate decision to dominate in week ahead, with BoE meeting likely to be dull
The corporate diary is fairly sparse, but there are some bright spots, notably updates from refocused blue chip hotels group Whitbread and housebuilder Berkeley Group
Investments and investor services
FTSE 100 closes in the red as trade tensions and Brexit confusion rumble on
The UK index of leading shares closed down nearly 38 points at 7,310
Archive
Still no opportunities to sell in May, with Royal Mail and M&S set to deliver updates
The Week Ahead will also bring news from power firm SSE and water groups Severn Trent and United Utilities, plus the latest UK inflation and retail sales numbers
Jefferies downgrades BTG as it rules out bidding war for the UK pharma group
Analysts at the US investment bank said in a note that they don’t expect any other bidders to come forward, so have cut their rating and target to reflect that
Webis weak on limited California license renewal; Kier Group drops on cash call
A look at some winners and losers in the UK equity market on Friday
FTSE 100 closes lower as G20 summit begins and trade worries continue; housebuilders fall
The premier index of UK shares finished down nearly 59 points at 6,980. Mid-cap cousin FTSE 250 shed over 128 points at 18,480.
BTG lifts full-year guidance again, this time on spike in sales of its snake bite anti-venom
The upgrade came alongside half-year results, in which BTG reported a 12% in revenue and a 35% jump in adjusted operating profits
Investments and investor services
FTSE 100 flatlines at close as sterling gains on Brexit optimism
The UK blue-chip benchmark closed up 0.68 at 7,053, while the FTSE 250 added over 174 points at 18,985
Archive
Taylor Wimpey and Vodafone to lead the way on a busy Tuesday in the City
The City diary is filled to the brim, with updates expected from Taylor Wimpey, McCarthy & Stone, Vodafone, Premier Foods, Experian and many more
Archive
Housebuilders to take centre stage again after Persimmon boss drama
The week ahead includes trading updates from Bovis Homes and Taylor Wimpey, full year results from McCarthy & Stone, interims from Royal Mail, Vodafone and Premier Foods along with a batch of UK data
BTG upgrades full-year sales forecasts following strong portfolio performance in first half
The FTSE 250 healthcare firm said it was upgrading its product sales forecasts for the combined Vascular and Oncology portfolios to 15%-17% growth for the year
BTG snaps up medical device maker Novate for up to US$150mln
Novate has developed Sentry, a vascular device designed to manage blood clots, which was recently deemed safe and effective by US regulators
Investments and investor services
FTSE 100 closes higher, bolstered by sterling's fall; rate rise doubts
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
As Ryanair's struggles continue can easyjet look to the blue skies?
Easyjet and Severn Treant are among the key names in the diary for Wednesday.
Archive
Week ahead: Investors hope Royal Mail delivers the goods and Unilever meets targets
The week ahead includes updates from Royal Mail, Unilever, Sports Direct, Rio Tinto and Anglo American along with official UK data on jobs, inflation and retail sales
Advisory committee tells US regulators to reject BTG’s Elevair emphysema treatment
The panel wasn’t convinced that Elevair would have any effect on those taking it, or that the possible benefits outweighed the risks
Investments and investor services
FTSE 100 closes higher but miners hit by Chinese data
Around 3.20pm, the UK blue-chip index was up 17 points to 7,728